Screening Young Children for Lead Poisoning: Guidance for State and Local Public Health Officials

Centers for Disease Control and Prevention (CDC)

Note: This document refers to various blood-lead thresholds and levels of concern for adverse health outcomes in children. This terminology is outdated and readers are referred to the ACCLPP recommendations of 2012.

Cover

November 3, 1997

February 21, 1997

NOTE: To obtain a printed copy of the screening document, please call (toll-free) 800-CDC-INFO (800-232-4636).

Document Sections No. of
Pages
Files
(Adobe Acrobat
PDF & GIF)
Cover page 1 cover.pdf pdf icon[89 KB]
 
Title page 2 title.pdf pdf icon[33 KB]
 
Contents
List of Tables and Figures
3 contents.pdf pdf icon[121 KB]
Forward 2 forward.pdf pdf icon[64 KB]
Preface (pages 1-3)
Advisory Committee on Childhood Lead Poisoning Prevention (pages 4-8)
Executive Summary (pages 9-12)
12 p1_12.pdf pdf icon[157 KB]
Chapter 1. Childhood Lead Poisoning in the United States (pages 13-20) 8 chapter1.pdf pdf icon[162 KB]
 
Chapter 2. A Comprehensive Approach to Childhood Lead Poisoning Prevention (pages 21-30) 10 chapter2.pdf pdf icon[170 KB]
 
Chapter 3. The Statewide Plan for Childhood Blood Lead Screening (pages 31-76) 46 chapter3.pdf pdf icon[299 KB]
Chapter 4. Role of Child Health-Care Providers in Childhood Lead Poisoning Prevention (pages 77-110) 34 chapter4.pdf pdf icon[199 KB]
Chapter 5. CDC Resources and Information for Implementation of Guidance (pages 111-114) 4 chapter5.pdf pdf icon[192 KB]
Chapter 6. Childhood Lead Poisoning Prevention Research Priorities (pages 115-116) 2 chapter6.pdf pdf icon[60 KB]
Glossary (pages 117-121) 5 glossary.pdf pdf icon[67 KB]
Appendix B.1 Blood Lead Levels in the United States. 1991-1994.

CDC. Update: Blood Lead Levels — United States, 1991-1994. MMWR 1997; 46(7):141-146.

6
Appendix B.2 Blood Lead Levels in the U.S. Population.

Brody DJ, Pirkle JL, Kramer RA, et al. Blood lead levels in the U.S. population. JAMA 1994; 272(4): 277-283.

8 jama277.gifimage icon [100 KB]
jama278.gifimage icon [112 KB]
jama279.gifimage icon [112 KB]
jama280.gifimage icon [78 KB]
jama281.gifimage icon [107 KB]
jama282.gifimage icon [75 KB]
jama283.gifimage icon [117 KB]
Appendix B.3 The Decline in Blood Lead Levels in the United States.

Brody DJ, Pirkle JL, Gunter EW, et al. The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES III). JAMA 1994; 272(4): 284-291.

8 jama284.gifimage icon [110 KB]
jama285.gifimage icon [105 KB]
jama286.gifimage icon [95 KB]
jama287.gifimage icon [111 KB]
jama288.gifimage icon [9 3KB]
jama289.gifimage icon [117 KB]
jama290.gifimage icon [104 KB]
jama291.gifimage icon [90 KB]
Appendix B.4 Costs and Benefits of a Universal Screening Program for Elevated Blood Lead Levels in 1-Year-Old Children 19 b4.pdf pdf icon[85 KB]
Appendix B.5 Relationship Between Prevalence of BLLs >=10 µg/dL and Prevalences Above Other Cut-Off Levels 2 b5.pdf pdf icon[25 KB]
Appendix B.6 Exact Confidence Intervals for Some Hypothetical Estimates of Prevalence of BLLs >=10 µg/dL, by Number of Children Screened 2 b6.pdf pdf icon[10KB]
Appendix B.7 Conditions Required for a Source of Lead to be a Hazard 1 b7.pdf pdf icon[9 KB]
Appendix C.1 The Lead Laboratory 20 c1.pdf pdf icon[75 KB]
Appendix C.2 Capillary Blood Sampling Protocol 5 c2.pdf pdf icon[27 KB]
Appendix C.3 Proficiency Testing and Quality Control
  • Table A. Proficiency Testing Programs for Lead Laboratories
  • Table B. Quality Control Materials for Use in Blood Lead Testing
  • Table C. Quality Control Materials for Use in Urine Lead Testing
  • Table D. Quality Control Materials for Erythorocyte Protoporphyrin Tests.
5 c3.pdf pdf icon[19 KB]

NOTE: To obtain a printed copy of the screening document, please call (toll-free) 800-CDC-INFO (800-232-4636).